As you read this, corporate advisers are preparing strategic options for Life Healthcare, in the wake of 22% shareholder Mvelaphanda announcing last September that it was realising and unbundling its assets. One option, say market sources, is a listing on the JSE, as early as May. Another is that 21.9% shareholder Brimstone Investment might snap up Mvela’s stake, valued at around R1.6bn.
Life Healthcare Group is currently valued at around R7.4bn. Brimstone and Tokyo Sexwale’s Mvela were the leaders in a BEE consortium that acquired the group. Their mission is simply to boost the bottom line.
But who will rush to buy Life Healthcare Group shares after reading this?
While every reasonable effort is taken to ensure the accuracy and soundness of the contents of this publication, neither the authors nor the publishers of this website bear any responsibility for the consequences of any actions based on the information contained therein.